Country Club Bank Sells 839 Shares of Kenvue Inc. $KVUE

Country Club Bank lowered its stake in Kenvue Inc. (NYSE:KVUE) by 0.3% during the second quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 247,126 shares of the company’s stock after selling 839 shares during the quarter. Country Club Bank’s holdings in Kenvue were worth $5,160,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Pittenger & Anderson Inc. bought a new position in Kenvue during the 1st quarter worth about $30,000. TruNorth Capital Management LLC bought a new stake in shares of Kenvue in the first quarter valued at about $36,000. Truvestments Capital LLC bought a new stake in shares of Kenvue in the first quarter valued at about $37,000. Trust Co. of Vermont boosted its position in shares of Kenvue by 266.8% during the second quarter. Trust Co. of Vermont now owns 1,581 shares of the company’s stock worth $33,000 after buying an additional 1,150 shares during the period. Finally, Clal Insurance Enterprises Holdings Ltd boosted its position in shares of Kenvue by 378.5% during the first quarter. Clal Insurance Enterprises Holdings Ltd now owns 1,627 shares of the company’s stock worth $39,000 after buying an additional 1,287 shares during the period. Institutional investors and hedge funds own 97.64% of the company’s stock.

Wall Street Analyst Weigh In

Several equities research analysts have commented on the company. Barclays cut their target price on Kenvue from $20.00 to $17.00 and set an “equal weight” rating on the stock in a research note on Wednesday, October 1st. JPMorgan Chase & Co. lowered their price objective on shares of Kenvue from $27.00 to $26.00 and set an “overweight” rating on the stock in a report on Friday, July 25th. Citigroup reissued a “neutral” rating on shares of Kenvue in a research report on Tuesday, September 23rd. Rothschild & Co Redburn upgraded shares of Kenvue from a “neutral” rating to a “buy” rating and reduced their target price for the stock from $22.50 to $22.00 in a report on Friday, September 26th. Finally, Redburn Partners set a $22.00 price target on shares of Kenvue in a research note on Friday, September 26th. One analyst has rated the stock with a Strong Buy rating, five have given a Buy rating, nine have given a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, the stock currently has an average rating of “Hold” and an average price target of $22.46.

Kenvue Trading Down 0.7%

Kenvue stock opened at $15.70 on Tuesday. The stock has a 50-day simple moving average of $19.58 and a 200 day simple moving average of $21.50. The stock has a market capitalization of $30.13 billion, a P/E ratio of 21.22, a PEG ratio of 2.27 and a beta of 0.72. The company has a debt-to-equity ratio of 0.66, a quick ratio of 0.68 and a current ratio of 0.98. Kenvue Inc. has a 52 week low of $15.47 and a 52 week high of $25.17.

Kenvue (NYSE:KVUE) last released its quarterly earnings data on Thursday, August 7th. The company reported $0.29 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.28 by $0.01. Kenvue had a return on equity of 20.06% and a net margin of 9.37%.The company had revenue of $3.84 billion during the quarter, compared to analysts’ expectations of $3.94 billion. During the same period last year, the firm posted $0.32 earnings per share. The business’s revenue was down 4.0% on a year-over-year basis. Kenvue has set its FY 2025 guidance at 1.000-1.050 EPS. Analysts expect that Kenvue Inc. will post 1.14 earnings per share for the current year.

Kenvue Increases Dividend

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, August 27th. Shareholders of record on Wednesday, August 13th were given a dividend of $0.2075 per share. This represents a $0.83 dividend on an annualized basis and a yield of 5.3%. This is a positive change from Kenvue’s previous quarterly dividend of $0.21. The ex-dividend date of this dividend was Wednesday, August 13th. Kenvue’s dividend payout ratio (DPR) is presently 112.16%.

Kenvue Profile

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.